PrognostiCheck® Value Proposition Strategy and Focus.
•
1 gostou•244 visualizações
PrognostiCheck® Value Proposition Strategy and Focus in detail.
Recomendados
Recomendados
Mais conteúdo relacionado
Semelhante a PrognostiCheck® Value Proposition Strategy and Focus.
Semelhante a PrognostiCheck® Value Proposition Strategy and Focus. (20)
Mais de IPGDx LLC
Mais de IPGDx LLC (13)
Último
Último (20)
PrognostiCheck® Value Proposition Strategy and Focus.
- 2. PROGNOSTICHECK® Value Proposition: Strategy & Focus
- 3. STRATEGY & FOCUS Reliable information to base healthcare decisions upon Scientific Excellent Compassionate knowledge training & caring base support communication Structured Specific to: Pre-Learning multi-media formats Patient, Physician, Assessment Manufacturer ©2005 IPGDx, LLC
- 4. INDIVIDUALLY TARGETED CURRICULUM • Patient’s and Families • Physicians – Other healthcare providers • Nurses • Facilities – Phase of care • Manufacturers – Pharmaceuticals/Other Interventions • Prescription • Nonprescription ©2005 IPGDx, LLC
- 5. THREE FRONTS OF CHANGE • Chronic disease model – Therapeutic efficacy • Healthcare delivery system – Changing roles • Ethical and cultural expectations – Duties and responsibilities within a new decision paradigm ©2005 IPGDx, LLC
- 6. CHRONIC DISEASE • Diagnosis established • Tx limited/repetitive • Course is long/progressive • Complications – Anticipation – Avoidance – Mitigation • Speed of progression • Scope of deterioration ©2005 IPGDx, LLC
- 7. CHARACTER OF CHRONIC ILLNESS • Nonfatal (Complication Avoidance) – Occurs with substantial reserve capacity – Progressively long natural course • Serious then fatal – Progressively worsening – Serial exacerbations to death • Frailty/prolonged dwindling (Cliff Edge) – Little available reserves – Small upset cascades ©2005 IPGDx, LLC
- 8. Hospitalizations • Severity of disease – Present on admission – Nosocomial or not • Overstaying DRG LOS – Complications • ICU Resource allocation – SIRS ©2005 IPGDx, LLC
- 9. From: ‘Living Well at the End of Life’; Lynn & Adamson 2003 Rand Health ©2005 IPGDx, LLC
- 10. ~20% ~20% ~40% ©2005 IPGDx, LLC *~20% other and/or undefined
- 11. ©2005 IPGDx, LLC
- 12. Of the ~2.5M annual deaths less than forty percent died under hospice care ©2005 IPGDx, LLC
- 13. THOSE WITH CHRONIC DISEASE ©2005 IPGDx, LLC
- 14. CHANGES IN HEALTHCARE DELIVERY • Physician – < economic independence – < professional autonomy – > external review – > administrative oversight • Called upon to: – Optimize outcome while minimizing costs – Proffer decisions with weighted administrative and clinical consequences ©2005 IPGDx, LLC
- 15. CHANGES IN HEALTHCARE DELIVERY • Resource Allocation – > need – > cost – To produce > benefit – Comparative metric/risk adjustments – Relative levels of illness and treatment • System comparisons ©2005 IPGDx, LLC
- 16. CHANGES IN HEALTHCARE DELIVERY • Demonstrated Effectiveness – Assessment of the probability of expected course and outcomes • Assumption of therapeutic efficacy – Intermediate endpoints predictive of long-term outcomes • Predictive findings • Pre-symptomatic – occult illness • Predicting consequences – Benefit of advanced interventions – Adherence metrics ©2005 IPGDx, LLC
- 17. ©2005 IPGDx, LLC
- 18. ETHICAL DECISION MAKING • Communication required • Consumerism • Informed consent • Risk (cost) / Benefit • Resources – Availability – Allocation ©2005 IPGDx, LLC
- 19. ©2005 IPGDx, LLC
- 20. END OF LIFE COSTS ©2005 IPGDx, LLC
- 21. CULTURAL EXPECTATIONS • Futility of intervention (flogging) • Outcome inevitability – Likelihood of recovery – Effectiveness v trauma of intervention • Justice • Beneficence • Economy ©2005 IPGDx, LLC
- 22. END OF LIFE CARE • > Consciousness of EOL care and death • ‘Good Death’ v “BAD” – Control-Comfort-Communication – Discussed with family – Planned for – Meaningful assessments – Management of – Home care • Physical-Spiritual-Emotional-Social-Cost ©2005 IPGDx, LLC
- 23. ©2005 IPGDx, LLC
- 24. ©2005 IPGDx, LLC
- 25. ©2005 IPGDx, LLC
- 26. ©2005 IPGDx, LLC
- 27. ©2005 IPGDx, LLC
- 28. PROGNOSTICHECK® • If Sick, How Sick® • Prognosis – Characterization of disease • Presence-Severity-Progression – Effectiveness of therapies • Optimized individual response – Timing of non-acute death • Palliative care and Hospice ©2005 IPGDx, LLC
- 29. TARGETED MARKET SEGMENTS Innovators First 5% - 10% that adopt the product Early Adopters Next 10% - 15% Early MajorityNext 30% Late Majority Next 30% Laggards Remaining 20% CHARACTERISTICS: Venturesomeness: the willingness and desire to be daring in trying something new and different Social integration: frequent and extensive contact with others in one’s area Cosmopolitan: point of view extending beyond the immediate neighborhood or community Social mobility: upward movement on the social scale Privilegedness: attitude and possession of money (less risky to try something new) ©2005 IPGDx, LLC
- 30. ©2005 IPGDx, LLC
- 31. ©2005 IPGDx, LLC